Literature DB >> 25784743

Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.

Thao P Nguyen1, Doug A Bazdar1, Joseph C Mudd1, Michael M Lederman1, Clifford V Harding1, Gareth A Hardy1, Scott F Sieg2.   

Abstract

Persistent type I IFN production occurs during chronic viral infections, such as HIV disease. As type I IFNs have antiproliferative activity, it is possible that chronic exposure to these cytokines could adversely affect T cell homeostasis. We investigated the capacity of IFN-α to impair T cell proliferation induced by the homeostatic cytokine, IL-7, or another common γ-chain cytokine, IL-2, in cells from healthy human donors. We found that IL-7- or IL-2-induced proliferation of CD4(+) T cells was partially inhibited in the presence of IFN-α. The CD4(+) T cells that were exposed to IFN-α also displayed attenuated induction of IL-2 and CD40L following TCR stimulation. Analyses of signaling pathways indicated that IL-7 and IL-2 induced a delayed and sustained P-Akt signal that lasted for several days and was partially inhibited by IFN-α. In contrast, IL-7-induced P-STAT5 was not affected by IFN-α. Furthermore, IFN-α had no detectable effect on P-Akt that was induced by the chemokine SDF-1. Both inhibitors of P-Akt and P-STAT5 blocked IL-7-induced T cell proliferation, confirming that both signaling pathways are important for IL-7-induced T cell proliferation. These results demonstrate that IFN-α can selectively inhibit cytokine-induced P-Akt as a potential mechanism to disrupt homeostasis of T lymphocytes. © Society for Leukocyte Biology.

Entities:  

Keywords:  cytokines; homeostatic proliferation

Mesh:

Substances:

Year:  2015        PMID: 25784743      PMCID: PMC4438745          DOI: 10.1189/jlb.4A0714-345RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  37 in total

1.  CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells.

Authors:  Sonia Fernandez; Sara Tanaskovic; Karla Helbig; Reena Rajasuriar; Marit Kramski; John M Murray; Michael Beard; Damian Purcell; Sharon R Lewin; Patricia Price; Martyn A French
Journal:  J Infect Dis       Date:  2011-10-17       Impact factor: 5.226

Review 2.  HIV-1 immunopathogenesis: how good interferon turns bad.

Authors:  Jean-Philippe Herbeuval; Gene M Shearer
Journal:  Clin Immunol       Date:  2006-11-16       Impact factor: 3.969

3.  Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes.

Authors:  Joseph C Mudd; Patrick Murphy; Maura Manion; Robert Debernardo; Jeffrey Hardacre; John Ammori; Gareth A Hardy; Clifford V Harding; Ganapati H Mahabaleshwar; Mukesh K Jain; Jeffrey M Jacobson; Ari D Brooks; Sharon Lewis; Timothy W Schacker; Jodi Anderson; Elias K Haddad; Rafael A Cubas; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

4.  Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).

Authors:  J T Barata; A A Cardoso; L M Nadler; V A Boussiotis
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

5.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

6.  Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression.

Authors:  Gareth A D Hardy; Scott F Sieg; Benigno Rodriguez; Wei Jiang; Robert Asaad; Michael M Lederman; Clifford V Harding
Journal:  Blood       Date:  2009-03-19       Impact factor: 22.113

7.  IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.

Authors:  Irini Sereti; Richard M Dunham; John Spritzler; Evgenia Aga; Michael A Proschan; Kathy Medvik; Catherine A Battaglia; Alan L Landay; Savita Pahwa; Margaret A Fischl; David M Asmuth; Allan R Tenorio; John D Altman; Lawrence Fox; Susan Moir; Angela Malaspina; Michel Morre; Renaud Buffet; Guido Silvestri; Michael M Lederman
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

8.  Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.

Authors:  Claude Sportès; Rebecca R Babb; Michael C Krumlauf; Frances T Hakim; Seth M Steinberg; Catherine K Chow; Margaret R Brown; Thomas A Fleisher; Pierre Noel; Irina Maric; Maryalice Stetler-Stevenson; Julie Engel; Renaud Buffet; Michel Morre; Robert J Amato; Andrew Pecora; Crystal L Mackall; Ronald E Gress
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

9.  Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.

Authors:  Claude Sportès; Frances T Hakim; Sarfraz A Memon; Hua Zhang; Kevin S Chua; Margaret R Brown; Thomas A Fleisher; Michael C Krumlauf; Rebecca R Babb; Catherine K Chow; Terry J Fry; Julie Engels; Renaud Buffet; Michel Morre; Robert J Amato; David J Venzon; Robert Korngold; Andrew Pecora; Ronald E Gress; Crystal L Mackall
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

10.  Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.

Authors:  Joseph A Fraietta; Yvonne M Mueller; Guibin Yang; Alina C Boesteanu; Donald T Gracias; Duc H Do; Jennifer L Hope; Noshin Kathuria; Shannon E McGettigan; Mark G Lewis; Luis D Giavedoni; Jeffrey M Jacobson; Peter D Katsikis
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more
  10 in total

1.  CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.

Authors:  Michael L Freeman; Joseph C Mudd; Carey L Shive; Souheil-Antoine Younes; Soumya Panigrahi; Scott F Sieg; Sulggi A Lee; Peter W Hunt; Leonard H Calabrese; Sara Gianella; Benigno Rodriguez; Michael M Lederman
Journal:  Clin Infect Dis       Date:  2015-09-23       Impact factor: 9.079

2.  Kynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection.

Authors:  Xavier Dagenais-Lussier; Mouna Aounallah; Vikram Mehraj; Mohamed El-Far; Cecile Tremblay; Rafick-Pierre Sekaly; Jean-Pierre Routy; Julien van Grevenynghe
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

3.  TGF-β inhibits IL-7-induced proliferation in memory but not naive human CD4+ T cells.

Authors:  Thao P Nguyen; Scott F Sieg
Journal:  J Leukoc Biol       Date:  2017-06-06       Impact factor: 4.962

4.  IL-7-dependent STAT1 activation limits homeostatic CD4+ T cell expansion.

Authors:  Cecile Le Saout; Megan A Luckey; Alejandro V Villarino; Mindy Smith; Rebecca B Hasley; Timothy G Myers; Hiromi Imamichi; Jung-Hyun Park; John J O'Shea; H Clifford Lane; Marta Catalfamo
Journal:  JCI Insight       Date:  2017-11-16

5.  IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.

Authors:  Souheil-Antoine Younes; Michael L Freeman; Joseph C Mudd; Carey L Shive; Arnold Reynaldi; Soumya Panigrahi; Jacob D Estes; Claire Deleage; Carissa Lucero; Jodi Anderson; Timothy W Schacker; Miles P Davenport; Joseph M McCune; Peter W Hunt; Sulggi A Lee; Sergio Serrano-Villar; Robert L Debernardo; Jeffrey M Jacobson; David H Canaday; Rafick-Pierre Sekaly; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

6.  Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection.

Authors:  Carey L Shive; Brian Clagett; Marie R McCausland; Joseph C Mudd; Nicholas T Funderburg; Michael L Freeman; Souheil-Antoine Younes; Brian M Ferrari; Benigno Rodriguez; Grace A McComsey; Leonard H Calabrese; Scott F Sieg; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-15       Impact factor: 3.731

7.  Responsiveness to IL-7 but not to IFN-α is diminished in CD4+ T cells from treated HIV infected patients who experience poor CD4+ T-cell recovery.

Authors:  Thao P Nguyen; Supriya Shukla; Robert Asaad; Michael L Freeman; Michael M Lederman; Clifford V Harding; Scott F Sieg
Journal:  AIDS       Date:  2016-08-24       Impact factor: 4.177

Review 8.  Role of immune activation in progression to AIDS.

Authors:  Netanya S Utay; Peter W Hunt
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

9.  Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy.

Authors:  Katharina Zoldan; Sabine Ehrlich; Saskia Killmer; Katharina Wild; Maike Smits; Marissa Russ; Anna-Maria Globig; Maike Hofmann; Robert Thimme; Tobias Boettler
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

10.  USP18 is a significant driver of memory CD4 T-cell reduced viability caused by type I IFN signaling during primary HIV-1 infection.

Authors:  Xavier Dagenais-Lussier; Hamza Loucif; Hugo Cadorel; Juliette Blumberger; Stéphane Isnard; Mariana Gé Bego; Éric A Cohen; Jean-Pierre Routy; Julien van Grevenynghe
Journal:  PLoS Pathog       Date:  2019-10-28       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.